Pharmascience
6
40M
5
0.15
1
0.17
1
- Areas of investment
Summary
Pharmascience appeared to be the Corporate Investor, which was created in 1983. The main department of described Corporate Investor is located in the Montru00e9al. The company was established in North America in Canada.
The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular fund investment industries, there are Medical, Life Science. Among the most popular portfolio startups of the fund, we may highlight Edesa Biotech, RDD Pharma.
Opposing the other organizations, this Pharmascience works on 4 percentage points more the average amount of lead investments. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 2-3 partakers. The meaningful sponsors for the fund in investment in the same round are Signet Healthcare Partners, OrbiMed, Lumira Ventures.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.15
- Follow on index
- 0.17
- Investments by industry
- Pharmaceutical (5)
- Biotechnology (4)
- Clinical Trials (2)
- Communities (2)
- Manufacturing (2) Show 5 more
- Investments by region
-
- United States (4)
- Israel (1)
- Canada (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 1.00
- Avg. company exit year
- 20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Edesa Biotech | 20 Sep 2017 | Biotechnology, Life Science | Early Stage Venture | 7M | Ontario, Markham, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.